Malignant Iymphoma 01 the central nervous system (CNS) have exhibition a marked response to radiation therapy, so that earl y diagnosis may be 01 valu e. The authors reviewed 19 patients with diffuse histiocytic Iymphoma 01 the brain, including 13 with primary disease and 6 with secondary disease. The results 01 treatment with radiation therapy (RT) and/or rad iation therapy lollowed by intrathecal methotraxate (MTx) were analyzed 80th primary and secondary Iymphomas exhibited the characteristic CT appearance, a largε solid, homogenously enhanced mass with varying amount 01 edema. Multilocallesions were also seen in primary (7/13) and secondary Iymphoma (2/6). Secondary Iymphoma affected the leptomeninges and subco rtical white matter w hich was contrasted with the involvement 01 deep cerebral nuclei and periventricular white matter in primary Iymphoma. The recurrence rate was higher in patients treated with RT alone (2/6) than RT and intrathecal MTx (1 /11), but necrotizing leukoencephalopathy was developed in 54.5% (6/11) 01 latter group.
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